Clinical trial
Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C
NCT00433108 · Antipodean Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00433108 |
|---|---|
| Title | Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C |
| Official title | A Double-Blind, Parallel, Randomized Comparison of Two Doses of MitoQ and Placebo for the Treatment of Patients With Raised Liver Enzymes Due to Hepatitis C |
| Lead sponsor | Antipodean Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Mitoquinone mesylate (MitoQ) |
| Enrollment | 30 |
| Start date | Mar 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Feb 9, 2007 |
| Last update posted | Aug 14, 2008 |
| Countries | New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: